Eagle Pharmaceuticals Inc.

(EGRX) Trade

By |

Profile

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, docetaxel injection, non-alcohol formulation and Bendeka. The company currently have multiple product candidates in advanced stages of development, and under review for approval by the Food and Drug Administration.

Contact Information

Website: www.eagleus.com
Email: info@eagleus.com
Main Phone: +1 201 326-5300
Address: 50 Tice Boulevard
Address 2: Suite 315
State: NJ
City / Town: Woodcliff Lake
Country: USA
Postal Code: 07677

Issuer Information

Exchange: NSD
CEO: Scott L. Tarriff
Employees: 96
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, docetaxel injection, non-alcohol formulation and Bendeka. The company currently have multiple product candidates in advanced stages of development, and under review for approval by the Food and Drug Administration.

Contact Information

Website: www.eagleus.com
Email: info@eagleus.com
Main Phone: +1 201 326-5300
Address: 50 Tice Boulevard
Address 2: Suite 315
State: NJ
City / Town: Woodcliff Lake
Country: USA
Postal Code: 07677

Issuer Information

Exchange: NSD
CEO: Scott L. Tarriff
Employees: 96
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 59.15 $ 0.39 (0.66%)
Last Price 59.15 Change $ 0.39 Change % 0.66 Tick N/A
Bid 58.00 Bid Size 300.00 Ask 95.00 Ask Size 100.00
Open 58.93 High 60.00 Low 57.75 Prev Close 58.76
Last Trade Volume 107,900 52 Wk Hi 70.13 52 Wk Low 36.03
Market Cap 808.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 13,666,880.00 EPS (TTM) 2.85 PE Ratio 19.50 Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 13
Number of Buys 1 11
Number of Sells 1 2
Net Activity 55209 107299
Last 10 Buys Shares
Pete A. Meyers 1,000
Douglas Braunstein 1,000
Douglas Braunstein 1,000
Douglas Braunstein 1,000
David Pernock 1,000
David Pernock 1,000
Richard A. Edlin 1,000
David Pernock 1,000
David Pernock 1,000
Michael Graves 1,000
Last 10 Sell Shares
Sander A. Flaum 1,000
Jay Moorin 1,000
Jay Moorin 1,000
Jay Moorin 1,000
Jay Moorin 1,000
Jay Moorin 1,000
Jay Moorin 1,000
Jay Moorin 1,000
Jay Moorin 1,000
Jay Moorin 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 78 78 78 78
Low Target Price Estimate 40 40 40 40
Mean Target Price Estimate 64.33 64.33 64.33 64.33
Standard Deviation 21.13 21.13 21.13 21.13
Date of Most Recent Estimate 05/10/18 05/10/18 05/10/18 05/10/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 1 1
Hold 1 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 1 1 0
Mean Rec. 1.67 2.33 2.25 1.33